胰岛素及口服降血糖药InsulinandOralHypoglycemicDrugsDiabetesisnotasingledisease.Instead,itisaheterogeneousgroupofsyndromesallcharacterizedbyanelevationofbloodglucosecausedbyarelativeorabsolutedeficiencyofinsulin.Frequentlytheinadequatereleaseofinsulinisaggravatedbyanexcessofglucagon.INSULINSULFOUNYLUREASBIGUANLDESα–GLUCOSIDASEINHIBITORTHIAZOLIDINEDIONEINTRODUCTIONSUMMARYINTRODUCTIONINTRODUCTIONINSULIN(胰岛素)INSULIN(胰岛素)SULFOUNYLUREAS(磺酰脲类)SULFOUNYLUREAS(磺酰脲类)SULFOUNYLUREAS(磺酰脲类)SULFOUNYLUREAS(磺酰脲类)THIAZOLIDINEDIONE(噻唑烷酮类)THIAZOLIDINEDIONE(噻唑烷酮类)α–GLUCOSIDASEINHIBITOR(α-葡萄糖苷酶抑制药)BIGUANLDES(双胍类)METFORMIN(甲福明)PHENFORMIN(苯乙福明)BUFORMIN(丁福明)HYPOGLYCEMICDRUGSINSULINRegularinsulinSemilanteinsulinLanteinsulinRotaminezincinsulinProtaminezincinsulinUltralanteinsulinORALHYPOGLYCEMICDRUGSSulfonylureasTolbutamideChlorpropamideGlibenclamideBiguanldesMetforminPhenformin-GlucosidaseinhibitorAcarboseVogliboseThiazolidinedioneRosiglitazoneCiglitazoneSUMMARY